QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics

Abstract EN

QTc interval prolongation is a side effect of several antipsychotic drugs, with associated risks of torsade de pointes arrhythmias and sudden cardiac death.

There is an ongoing debate of whether or not electrocardiogram (ECG) assessments should be mandatory in patients starting antipsychotic drugs.

To investigate QTc prolongation in a clinically relevant patient group 171 adult patients acutely admitted to an emergency ward for psychosis were consecutively recruited.

ECGs were recorded at baseline and then at discharge or after 6 weeks at the latest (discharge/6 weeks), thus reflecting the acute phase treatment period.

The mean QTc interval was 421.1 (30.4) ms at baseline and there was a positive association between the QTc interval and the agitation score whereas the QTc interval was inversely associated with the serum calcium level.

A total of 11.6% had abnormally prolonged QTc intervals and another 14.3% had borderline prolongation.

At discharge/6 weeks, the corresponding proportions were reduced to 4.2% and 5.3%, respectively.

The reduction of the proportion with prolonged QTc intervals reached statistical significance (chi-square exact test: P=0.046).

The finding of about one-quarter of the patients with borderline or prolonged QTc intervals could indicate mandatory ECG recordings in this population.

This trial is registered with ClinicalTrials.gov ID: NCT00932529.